Considering the in vitro anti-tumor effects of the novel isolated anti-PD-L1 mAb and its high affinity variants on breast cancer cells we made the hypothesis that PD-L1 may play by itself a role on tumor cells, by inducing cell proliferation, and anti-PD-L1 mAbs might inhibit its effects. Here, CD274 is linked to breast carcinoma.